Is Actuate Therapeutics, Inc. Common stock (ACTU) undervalued? · $49.0M cap
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
This page asks whether Actuate Therapeutics, Inc. Common stock (ACTU) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Without a cached income statement, “undervalued ACTU” is a slogan. Wait for the print.
ACTU currently screens at market cap $49.0M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new ACTU 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare ACTU to the stock page model before you treat a low multiple as a gift.
Not investment advice.